Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Study of Postoperative Ileus in Digestive Surgery

NCT06018961 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2024-04-24
Last updated
2025-12-31

Condition(s) studied

Colorectal Surgery

Investigational drug(s) / intervention(s)

Post-operative ileus surgery

Post-operative ileus surgery: Collection of ileus events, items of IFEED score and surgical complications

Study summary

Post-operative ileus is a temporary stoppage of bowel function following surgery. Indeed it can occur in 20% of cases during post-operative follow-up of bowel surgery. The absence of resumption of transit can lead to the implementation of specific treatments such as the placement of a nasogastric tube and drug treatments. To date, the definition of this event is not accepted by everyone and is not based on reproducible evaluation criteria. The main objective of this study is to evaluate a score used to date to define postoperative ileus, the IFEED score, and to compare it to the length of postoperative stay.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient entering our care sector for surgical management of a pathology affecting the digestive tract: * Colorectal cancer * Chronic inflammatory bowel disease * Colonic diverticulosis. Exclusion Criteria: * Patient treated for digestive resection with associated resection procedure or to be treated with intraperitoneal chemotherapy. * Patient presenting during hospitalization with an ileus secondary to another intra-abdominal complication. * Patient cared for in an emergency * Hepatic resection or other associated metastatic site * Multiple digestive resection * Colorectal anastomosis less than 7 cm from the anal margin (below the Pouch of Douglas) * Patient with American Society of Anesthesiologists physical status (ASA) score \> 2 * Patient with an Eastern Cooperative Oncology Group (ECOG) Performance Status Scale \>2 * Pregnant or breastfeeding women * Patient under a protection regime for adults (guardianship, curators, safeguard of justice)

Primary outcome measure(s)

  • Complications of post-operative ileus surgery — 1 month
    Correlation between length of stay and Intake-Feeling nauseated-Emesis-physical Exam-Duration of symptoms (IFEED) score.

Trial sites (2)

FacilityCityRegionStatus
CHU de Toulouse Toulouse France Recruiting
INSERM Toulouse France Not Yet Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06018961 on ClinicalTrials.gov ↗ ← All trials in France